“…Clinical studies have shown that both salmeterol xinafoate, [15][16][17] a highly selective, long-acting, inhaled bronchodilator, and theophylline, 18,19 an oral derivative of xanthine, decrease the incidence of nocturnal asthma symptoms and reduce early morning bronchoconstriction. The effects of inhaled agonists and xanthine derivatives on sleep architecture and subjective sleep quality have been examined with inconclusive results.…”